To access this element change to forms mode OFF
Grant Award View - GA205208
Development of multifaceted glucose-plus therapies - A focus on...
GA ID:
GA205208
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
13-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$1,087,328.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Development of multifaceted glucose-plus therapies - A focus on Hexosaminidase A (HEXA)
Purpose:
Type 2 diabetes (T2D) is a cause of heart attacks, stroke, and kidney failure. Patients with T2D also commonly suffer from liver disease and increased blood lipids. We have recently identified Hexosaminidase A (HEXA) as a protein secreted by the liver that reduces high blood glucose levels and blood lipids, and improves insulin sensitivity and liver disease in diabetic mice. This project will investigate if HEXA is a useful therapeutic target for the treatment of metabolic disease.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2011540
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC
Postcode:
Multiple
Country:
AUSTRALIA